MENU
Zantac is a widely used heartburn medication considered safe enough to be sold over the counter — has been found to contain a cancer-causing chemical. This discovery has led to a U.S. Food and Drug Administration (FDA) investigation and subsequent recall of Zantac and generic versions of the drug (Ranitidine).
Since reaching the market in 1981, Zantac has been widely used to treat conditions such as acid reflux, heartburn, and ulcers. The drug is frequently prescribed by healthcare providers but is also available as an over the counter medication.
A study performed by online pharmacy Valisure in September of 2019 found that Zantac and its generic equivalent Ranitidine was tainted with an unsafe level of the cancer-causing chemical NDMA. This finding led the FDA to alert patients and health care professionals. In addition, the FDA encouraged drug manufacturers to test their products and voluntarily recall any products with NDMA levels above the acceptable daily intake (ADI).
Zantac (Ranitidine)
Manufacturer: Sanofi
Did you take the brand-name Zantac (Rantitidine) for one year or more and suffered one or more of the following side effects/injuries (Note: you have not been previously diagnosed with the same cancer prior to taking Zantac):
CONTACT GOLDBLATT SINGER TO GET THE COMPENSATION YOU DESERVE
We are deeply troubled that a drug trusted by millions of patients was tainted and could cause cancer. If you or a family member believe you are suffering from serious complications and side effects associated with Zantac, first see a physician. Then, call our experienced attorneys to arrange a free, no obligation, and completely confidential consultation and are prepared to file lawsuits on your behalf.